RB1突变通过调节细胞染色体P450通路诱导吸烟相关的膀癌
Zhenguang Mao1,2, Fang Gao1,3, Tuo Sun1,2
1Department of Environmental Genomics and Genetic Toxicology, The Key Laboratory of Modern Toxicology of Ministry of Education, Center for Global Health, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China.
Environmental toxicology
|September 6, 2024
概括
吸烟通过改变RB1基因,一个关键的驱动因素,增加了膀癌的风险. RB1突变破坏细胞功能和免疫微环境,促进吸烟者的瘤生长.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 环境健康 环境健康
背景情况:
- 吸烟是已知的致癌物质,与各种癌症有关,包括膀癌.
- 吸烟诱导的体质突变驱动膀瘤发生的精确机制尚未完全理解.
- 了解这些机制对于制定有针对性的预防和治疗策略至关重要.
研究的目的:
- 描述膀癌中与吸烟相关的突变特征.
- 确定与吸烟相关的驱动基因并阐明它们的生物机制.
- 研究RB1突变在与吸烟相关的膀癌发展中的作用.
主要方法:
- 对癌症基因组图谱 (TCGA) 队列对吸烟相关突变概况的分析.
- 利用整合性瘤基因组学数据库来识别驱动基因.
- 使用散装和单细胞转录组学以及细胞实验来解释生物机制.
- 实时定量PCR (RT-qPCR) 用于基因表达分析.
主要成果:
- 吸烟与65岁以下人群的瘤突变负担增加有关.
- 在吸烟者中,RB1被确定为显著差异突变的驱动基因,突变率增加了两倍.
- 由吸烟致癌物质影响的RB1突变,如4-aminobiphenyl,减少RB1的表达,促进癌细胞的增殖,入侵和迁移.
- 发现RB1突变抑制了细胞染色体P450通路,并通过增强的细胞相互作用改变免疫细胞组成.
结论:
- RB1突变是吸烟相关的膀瘤发生的关键驱动因素.
- 通过RB1突变抑制细胞染色体P450通路和调节瘤免疫微环境,有助于癌症的发展.
- 这项研究提供了关于吸烟与膀癌相关的分子机制的关键见解.
相关概念视频
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Mutations
81.1K
Overview
81.1K
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


